Vivek Ramaswamy insider trades

Open-market stock purchases and sales by Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd, from SEC Form 4 filings since Aug 12, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -83%.

Recent trades

DateStockTradeValue
Dec 15, 2025ROIV Roivant Sciences LtdSold$7.8M
Dec 15, 2025ROIV Roivant Sciences LtdSold (not open market)$10.6M
Dec 15, 2025ROIV Roivant Sciences LtdBought (not open market)—
Dec 12, 2025ROIV Roivant Sciences LtdSold$43.4M
Dec 12, 2025ROIV Roivant Sciences LtdSold (not open market)$59.2M
Dec 12, 2025ROIV Roivant Sciences LtdBought (not open market)—
Dec 11, 2025ROIV Roivant Sciences LtdSold$16.8M
Dec 11, 2025ROIV Roivant Sciences LtdSold (not open market)$23.7M
Dec 11, 2025ROIV Roivant Sciences LtdBought (not open market)—
Nov 17, 2025ROIV Roivant Sciences LtdSold$11.1M
Nov 14, 2025ROIV Roivant Sciences LtdSold$20.9M
Nov 13, 2025ROIV Roivant Sciences LtdSold$6M
Nov 5, 2025ASST Strive, IncBought$1.3M

Companies traded

  • ROIV Roivant Sciences Ltd: 17 sales, last Dec 15, 2025
  • ASST Strive, Inc: 1 buy, last Nov 5, 2025
  • ABUS Arbutus Biopharma Corp: other filings, last Jun 19, 2018
  • AXON Axovant Sciences Ltd: other filings, last Apr 29, 2016

Get free alerts when Vivek Ramaswamy files a new trade →